How CRISPR Tech Supports Rare Genetic Disease Diagnosis
CRISPR technology helped researchers activate genes in easily accessible cells, which could revolutionize the diagnosis of genetic diseases.
Read MorePosted by Andy Lundin | Jan 25, 2024 | Diagnostic Technologies |
CRISPR technology helped researchers activate genes in easily accessible cells, which could revolutionize the diagnosis of genetic diseases.
Read MorePosted by Andy Lundin | Apr 4, 2023 | Amplification Technologies, Prostate |
A new study informed use of PARP inhibitors beyond BRCA1/2-deficient tumors and reevaluated biomarkers for PARP inhibition in prostate cancer.
Read MorePosted by Andy Lundin | Feb 21, 2023 | Amplification Technologies |
The USPTO granted Sherlock Biosciences a patent for the diagnostic use of the Cas12 enzyme, establishing it as CRISPR diagnostics provider.
Read MorePosted by Andy Lundin | Feb 1, 2023 | Amplification Technologies |
Researchers have developed a diagnostic method that can detect small amounts of cancer-related molecules in exosomes in plasma.
Read MorePosted by Andy Lundin | Jan 4, 2023 | Amplification Technologies |
A new CRISPR protein discovery holds potential for the development of new inexpensive and highly sensitive at-home diagnostic tests.
Read More